pfizer glp 1 news Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race Is Pfizer on Track to

Why the caveats: Most human data is observational, not randomized controlled trials designed to prove prevents dementia. So far, we cannot definitively say GLP-1 RAs prevent Alzheimers

Poll suggests millions want access to GLP1 drugs but are blocked by cost and limited coverage

GLP-1s offer treatment for diabetes, obesity, heart disease and morebut there are caveats

Here we talk about GLP-1 weight loss for women in perimenopause, as well as talk through GLP-1 side effects in women and microdosing GLP-1 benefits.

This is all well and good for people with obesity (PwO) who also have diabetes, but what if Mr T had obesity without diabetes

Novo Nordisk, Eli Lilly, Pfizer, Amgen and others are all competing to develop stronger and more convenient weight loss drugs